Shopping Cart
Remove All
Your shopping cart is currently empty
Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $289 | In Stock | In Stock | |
| 5 mg | $689 | In Stock | In Stock | |
| 10 mg | $1,070 | - | In Stock | |
| 25 mg | $1,590 | - | In Stock | |
| 50 mg | $2,150 | - | In Stock |
| Description | Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma. |
| In vitro | Bersanlimab(BI-505) induces dose-dependent expression of ICAM-1 and programmed cell death (PCD) in Ramos, Raji, and Daudi lymphoma cells, with a dosage range spanning from 1 ng/mL to 1000 μg/mL [1]. |
| In vivo | Bersanlimab (BI-505), administered at a dose of 20 mg/kg via intraperitoneal injection twice a week for a continuous period of 21 days, significantly reduces tumor growth and prolongs the survival of animals [1]. |
| Synonyms | BI-505 |
| Molecular Weight | 144.22 kDa |
| Cas No. | 1987854-08-9 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.